Cost-effectiveness of single-day intravenous fosaprepitant versus three-day oral aprepitant anti-emetic regimen in pediatric patients receiving highly-emetogenic chemotherapy. This is an ASCO Meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results